Trials / Completed
CompletedNCT01109693
Strategic Use of New Generation Antidepressants for Depression
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 2,011 (actual)
- Sponsor
- Kyoto University · Academic / Other
- Sex
- All
- Age
- 25 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to establish the optimum treatment strategy for first-line and second-line antidepressants in the acute phase treatment of major depression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sertraline | Sertraline 50 mg/d or 100 mg/d for 6 more weeks |
| DRUG | Mirtazapine | Augment with or switch to mirtazapine 15-45 mg/d |
Timeline
- Start date
- 2010-12-01
- Primary completion
- 2015-09-01
- Completion
- 2015-12-01
- First posted
- 2010-04-23
- Last updated
- 2016-10-03
Locations
2 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01109693. Inclusion in this directory is not an endorsement.